Posted by Clinical Lab Products | Aug 2, 2004 | Molecular Diagnostics |
By Tiffany Olson Tiffany Olson Laboratory administrators, like other executives, sometimes get so preoccupied with their day-to-day work issues that they fail to adjust to the shifting ground in their industry. The risk of becoming competitively
Read MorePosted by Clinical Lab Products | Jun 10, 2004 | Cancer, Clinical Chemistry, Clinical Chemistry Analyzers, Clinical Chemistry Test Kits, Miscellaneous |
Current Biomarker Study Seeks More Accurate Diagnosis of ALS The Amyotrophic Lateral Sclerosis Association (ALSA) is currently funding a year-long study to find a more rapid and accurate diagnostic test for amyotrophic lateral sclerosis (ALS) usi
Read MorePosted by Clinical Lab Products | Mar 1, 2004 | Miscellaneous |
By Marleen and Gary Wolfe The basic theory underlying the physician’s office laboratory (POL) is deceptively simple: If physicians can run certain critical assays on patients while they are in the office, the patients can be diagnosed and tr
Read MorePosted by Clinical Lab Products | Jan 10, 2004 | Cancer, Miscellaneous |
ASH Meeting Addresses Developments in Treating Blood Disorders Approximately 20,000 physicians and scientists from around the world gathered for the 45th Annual Meeting of the American Society of Hematology (ASH), December 6–9, 2003, at the S
Read MorePosted by Clinical Lab Products | Dec 11, 2003 | Miscellaneous, Osteoporosis |
AusAm Biotechnologies Receives Approval to Market Test for Kidney Disease AusAm Biotechnologies Inc has received the CE Mark of approval for the Microalbumin Plus™, which aids in the detection of microalbuminari
Read More